or Try an Advanced Search...

    Technical Analysis for SGMT - Sagimet Biosciences Inc.

    Grade Last Price % Change Price Change
    F 3.16 -7.60% -0.26
    SGMT closed down 7.6 percent on Monday, July 1, 2024, on 1.39 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SGMT trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    180 Bearish Setup Bearish Swing Setup -7.60%
    Expansion Breakdown Bearish Swing Setup -7.60%
    Volume Surge Other -7.60%
    Wide Bands Range Expansion -7.60%
    Gapped Down Weakness -7.60%
    Older End-of-Day Signals for SGMT ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 8 hours ago
    Fell Below Lower Bollinger Band about 8 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Up 5% about 10 hours ago
    Up 3% about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SGMT Chart by TradingView
    Basic chart:

    Profile

    Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases, such as non-alcoholic steatohepatitis, acne, and various cancers. It offers Denifanstat, a fatty acid synthase inhibitor for the treatment of nonalcoholic steatohepatitis. The company also develops TVB-3567, a FASN inhibitor. Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. The company was incorporated in 2006 and is based in San Mateo, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Acne

    Is SGMT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 Sagimet Biosciences (NASDAQ:SGMT) Is In A Good Position To Deliver On Growth Plans
    Jun 10 Sagimet Biosciences to Host Conference Call and Webcast to Discuss Recently Presented Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat
    Jun 6 Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024
    May 16 Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
    May 16 Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024
    May 15 Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    May 7 Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024
    May 6 Sagimet Biosciences gets new finance head
    May 6 Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
    Apr 26 Sagimet Biosciences' Denifanstat Imminent Phase 3: A Promising Investment Opportunity
    See more SGMT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.71
    52 Week Low 2.13
    Average Volume 584,559
    200-Day Moving Average 5.76
    50-Day Moving Average 4.46
    20-Day Moving Average 4.36
    10-Day Moving Average 3.90
    Average True Range 0.42
    RSI (14) 31.51
    ADX 19.71
    +DI 14.36
    -DI 30.96
    Chandelier Exit (Long, 3 ATRs) 4.45
    Chandelier Exit (Short, 3 ATRs) 4.40
    Upper Bollinger Bands 5.50
    Lower Bollinger Band 3.23
    Percent B (%b) -0.03
    BandWidth 52.02
    MACD Line -0.32
    MACD Signal Line -0.19
    MACD Histogram -0.1232
    Fundamentals Value
    Market Cap 95.99 Million
    Num Shares 30.4 Million
    EPS -1.18
    Price-to-Earnings (P/E) Ratio -2.68
    Price-to-Sales 99.52
    Price-to-Book 1.96
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.84
    Resistance 3 (R3) 3.91 3.75 3.72
    Resistance 2 (R2) 3.75 3.58 3.72 3.68
    Resistance 1 (R1) 3.46 3.48 3.38 3.39 3.65
    Pivot Point 3.30 3.30 3.27 3.27 3.30
    Support 1 (S1) 3.01 3.13 2.93 2.94 2.67
    Support 2 (S2) 2.85 3.03 2.82 2.64
    Support 3 (S3) 2.56 2.85 2.60
    Support 4 (S4) 2.49